Voluntary benefits available to UC faculty and staff

It’s annual enrollment season! Take a few minutes to learn about your UC benefits – including UC’s voluntary benefit plans

Voluntary Benefits: Critical Illness Plan and the Accident Insurance Plans

Over the past several years, UC faculty and staff have been able to enroll in Unum’s voluntary benefit plans – Unum’s Critical Illness and Accident insurances.   These plans are offered being offered again during this year’s annual enrollment period to benefit-eligible employees.

Critical Illness Insurance can help fill a financial gap if you or a covered family member experiences a severe, life-threatening illness. This benefit goes above and beyond the coverage provided under UC's medical plans.

Accident Insurance is designed to protect your finances by helping you pay for the unexpected costs associated with an accidental injury. Accident insurance includes benefits for a wide range of common injuries and covered accidents.

Both the Critical Illness Plan and the Accident Insurance Plans include a $50 Wellness benefit. 

For more information about the plans, visit the 2018 Annual Enrollment page.

Questions?

Reach out to UC Benefits at benefits@uc.edu or 513-556-6381. 

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.